Three experts discuss the increased mortality risk for patients with diabetic retinopathy, available screening tools, and ...

Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...

The following is a summary of “Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study,” published in the January 2025 issue of Ophthalmology by ...

The course has an emphasis on optical coherence tomography (OCT) interpretation, diabetic retinopathy grading, AMD classification and the identification and management of acute retinal pathology.

Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients ...

It is expected around 60,000 people who are already showing signs of eye disease will take part in OCT screening, which will be offered to people at higher risk of diabetic retinopathy.

During the examinations doctors are looking for signs of diabetic retinopathy ... and an operation to remove blood or scar tissue. The OCT scans are more advanced than traditional scans and ...

Background: This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR) in type 2 diabetic patients and their contributing factors. Methods: 199 type 2 ...

EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

Diabetic retinopathy involves the changes for the blood vessels in your eye due to the high sugars that are in your body from diabetes, if you're a diabetic and you notice changes to your vision ...